NeuroMetrix Inc. announced that it has appointed Frank McGillin as Senior Vice President and General Manager, Consumer. Mr. McGillin will be responsible for development of a consumer healthcare business built on the company's wearable therapeutic technology for treatment of chronic pain which was recently cleared by the FDA for over-the-counter use without a prescription requirement. Mr. McGillin brings to the company over 20 years experience building successful, high-growth consumer brands most recently at Philips Oral Healthcare and at Johnson & Johnson.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.96 USD | +2.86% | -2.07% | +10.00% |
19/04 | Sector Update: Health Care Stocks Advance Late Afternoon | MT |
19/04 | Sector Update: Health Care Stocks Rise Friday Afternoon | MT |
1st Jan change | Capi. | |
---|---|---|
+10.00% | 7.87M | |
-5.56% | 181B | |
-0.11% | 108B | |
-6.17% | 66.12B | |
+2.64% | 50.65B | |
+6.58% | 43.66B | |
+4.91% | 41.3B | |
+21.98% | 31.6B | |
+14.45% | 25.03B | |
-5.81% | 24.16B |
- Stock Market
- Equities
- NURO Stock
- News NeuroMetrix, Inc.
- NeuroMetrix Appoints Frank McGillin as Senior Vice President and General Manager, Consumer